A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
Work
Year: 2021
Type: article
Abstract: Introduction/Aims Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative illness with great unmet patient need. We aimed to evaluate whether mesenchymal stem cells induced to secrete high l... more
Source: Muscle & Nerve
Institutions Massachusetts General Hospital, Harvard University, Circuit Therapeutics (United States), University of California, Irvine, UC Irvine Health +5 more
Cites: 19
Cited by: 71
Related to: 10
FWCI: 8.09
Citation percentile (by year/subfield): 99.99
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $4,530
Funder ALS Association